The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The association between myelodysplastic syndromes (MDS) and inflammatory bowel diseases (IBD): Analysis of Nationwide Inpatient Sample (NIS) database.
 
Mali Barbi
No Relationships to Disclose
 
Sakteesh Gurunathan
No Relationships to Disclose
 
Kith Pradhan
No Relationships to Disclose
 
Balazs Halmos
Consulting or Advisory Role - Apollomics; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Foundation Medicine; Genentech/Roche; Guardant Health; Lilly; Merck; Novartis; Pfizer; Spectrum Pharmaceuticals; Takeda; Turning Point Therapeutics
Research Funding - Abbvie (Inst); Advaxis (Inst); AstraZeneca (Inst); Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Elevation Oncology; GlaxoSmithKline (Inst); Guardant Health (Inst); Janssen Oncology (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Takeda (Inst)
 
Kira Gritsman
No Relationships to Disclose
 
Amit K. Verma
Stock and Other Ownership Interests - Stelexis Therapeutics; ThromboGenics
Honoraria - Acceleron Pharma; Celgene; Stelexis Therapeutics
Consulting or Advisory Role - Janssen; Novartis
Research Funding - Bristol-Myers Squibb (Inst); Janssen Oncology (Inst)